Abstract
Resveratrol and quercetin are among the most studied plant polyphenols, and have many health-promoting actions. Strategies to accumulate them into mitochondria may be of therapeutic relevance, since these compounds are redox active and are well known to impact mitochondria and mitochondrial proteins. We report here the procedures to synthesize mitochondria-targeted resveratrol and quercetin derivatives; the synthetic strategies reported are however expected to be adaptable to other polyphenols with similar reactivity at the phenolic hydroxyls.
Mitochondrial targeting can be achieved by conjugation with triphenylphosphonium , a lipophilic cation; this was linked via a butyl spacer forming an ether bond with one of the phenolic oxygens. The first step toward the synthesis of all mitochondriotropic derivatives described in this work is the production of a regiospecific -(4-O-chlorobutyl) derivative. Triphenylphosphonium (P+Ph3I−) is then introduced through two consecutive nucleophilic substitution steps: –Cl → –I → –P+Ph3I−. Pure mono-substituted chlorobutyl regioisomers are obtained by purification from the reaction mixture in the case of resveratrol , while specific protection strategies are required for quercetin to favor alkylation of one specific hydroxyl.
Functionalization of the remaining hydroxyls can be exploited to modulate the physicochemical properties of the derivatives (i.e., water solubility, affinity for cell membranes); we report here synthetic protocols to obtain acetylated and methylated analogs.
A brief description of some methods to assess the accumulation of the derivatives in mitochondria is also given; the proposed techniques are the use of a TPP +-selective electrode (with isolated rat liver mitochondria ) and fluorescence microscopy (with cultured cells).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbaszadeh H, Keikhaei B, Mottaghi S (2019) A review of molecular mechanisms involved in anticancer and antiangiogenic effects of natural polyphenolic compounds. Phytother Res 33:2002–2014
Gorzynik-Debicka M, Przychodzen P, Cappello F, Kuban-Jankowska A, Marino Gammazza A, Knap N, Wozniak M, Gorska-Ponikowska M (2018) Potential health benefits of olive oil and plant polyphenols. Int J Mol Sci 19:686
Xing L, Zhang H, Qi R, Tsao R, Mine Y (2019) Recent advances in the understanding of the health benefits and molecular mechanisms associated with green tea polyphenols. J Agric Food Chem 67:1029–1043
Silvester AJ, Aseer KR, Yun JW (2019) Dietary polyphenols and their roles in fat browning. J Nutr Biochem 64:1–12
Russo GL, Spagnuolo C, Russo M, Tedesco I, Moccia S, Cervellera C (2019) Mechanisms of aging and potential role of selected polyphenols in extending healthspan. Biochem Pharmacol 173:113719
Reyes-Farias M, Carrasco-Pozo C (2019) The anti-cancer effect of quercetin: molecular implications in cancer metabolism. Int J Mol Sci 20:3177
Jiang Z, Chen K, Cheng L, Yan B, Qian W, Cao J, Li J, Wu E, Ma Q, Yang W (2017) Resveratrol and cancer treatment: updates. Ann N Y Acad Sci 1403:59–69
Halliwell B (2008) Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 476:107–112
De Marchi U, Biasutto L, Garbisa S, Toninello A, Zoratti M (2009) Quercetin can act either as an inhibitor or an inducer of the mitochondrial permeability transition pore: a demonstration of the ambivalent redox character of polyphenols. Biochim Biophys Acta 1787:1425–1432
Calabrese V, Cornelius C, Trovato A, Cavallaro M, Mancuso C, Di Rienzo L, Condorelli D, De Lorenzo A, Calabrese EJ (2010) The hormetic role of dietary antioxidants in free radical-related diseases. Curr Pharm Des 16:877–883
Hou DX, Kumamoto T (2010) Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modeling. Antioxid Redox Signal 13:691–719
Seifried HE, Anderson DE, Fisher EI, Milner JA (2007) A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 18:567–579
Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7:1020–1035
Jardim FR, de Rossi FT, Nascimento MX, da Silva Barros RG, Borges PA, Prescilio IC, de Oliveira MR (2018) Resveratrol and brain mitochondria: a review. Mol Neurobiol 55:2085–2101
Sajadimajd S, Bahramsoltani R, Iranpanah A, Kumar Patra J, Das G, Gouda S, Rahimi R, Rezaeiamiri E, Cao H, Giampieri F et al (2019) Advances on natural polyphenols as anticancer agents for skin cancer. Pharmacol Res 151:104584
Lejri I, Agapouda A, Grimm A, Eckert A (2019) Mitochondria- and oxidative stress-targeting substances in cognitive decline-related disorders: from molecular mechanisms to clinical evidence. Oxidative Med Cell Longev 2019:9695412
Ashrafizadeh M, Ahmadi Z, Farkhondeh T, Samarghandian S (2020) Resveratrol targeting the Wnt signaling pathway: a focus on therapeutic activities. J Cell Physiol 235(5):4135–4145
Tavana E, Mollazadeh H, Mohtashami E, Modaresi SMS, Hosseini A, Sabri H, Soltani A, Javid H, Afshari AR, Sahebkar A (2019) Quercetin: a promising phytochemical for the treatment of glioblastoma multiforme. BioFactors 46:356–366
Rauf A, Imran M, Khan IA, Ur-Rehman M, Gilani SA, Mehmood Z, Mubarak MS (2018) Anticancer potential of quercetin: a comprehensive review. Phytother Res 32:2109–2130
Lin X, Wu G, Huo WQ, Zhang Y, Jin FS (2012) Resveratrol induces apoptosis associated with mitochondrial dysfunction in bladder carcinoma cells. Int J Urol 19:757–764
Delmas D, Solary E, Latruffe N (2011) Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr Med Chem 18:1100–1121
Liu KC, Yen CY, Wu RS, Yang JS, Lu HF, Lu KW, Lo C, Chen HY, Tang NY, Wu CC et al (2012) The roles of endoplasmic reticulum stress and mitochondrial apoptotic signaling pathway in quercetin-mediated cell death of human prostate cancer PC-3 cells. Environ Toxicol 29(4):428–439
Rodriguez-Enriquez S, Pacheco-Velazquez SC, Marin-Hernandez A, Gallardo-Perez JC, Robledo-Cadena DX, Hernandez-Resendiz I, Garcia-Garcia JD, Belmont-Diaz J, Lopez-Marure R, Hernandez-Esquivel L et al (2019) Resveratrol inhibits cancer cell proliferation by impairing oxidative phosphorylation and inducing oxidative stress. Toxicol Appl Pharmacol 370:65–77
Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377–1382
Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230s–242s
Dabeek WM, Marra MV (2019) Dietary quercetin and Kaempferol: bioavailability and potential cardiovascular-related bioactivity in humans. Nutrients 11:2288
Petersen B, Egert S, Bosy-Westphal A, Muller MJ, Wolffram S, Hubbermann EM, Rimbach G, Schwarz K (2016) Bioavailability of quercetin in humans and the influence of food matrix comparing quercetin capsules and different apple sources. Food Res Int 88:159–165
Burak C, Brull V, Langguth P, Zimmermann BF, Stoffel-Wagner B, Sausen U, Stehle P, Wolffram S, Egert S (2017) Higher plasma quercetin levels following oral administration of an onion skin extract compared with pure quercetin dihydrate in humans. Eur J Nutr 56:343–353
Svilar L, Martin JC, Defoort C, Paut C, Tourniaire F, Brochot A (2019) Quantification of trans-resveratrol and its metabolites in human plasma using ultra-high performance liquid chromatography tandem quadrupole-orbitrap mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 1104:119–129
Garg R, Sardana S (2017) Research Problems Associated with Resveratrol (trans-3, 5, 4′- trihydroxystilbene; RSV) and Various Strategies to Overcome those Problems (Review). Curr Drug Deliv 14:364–376
Biasutto L, Mattarei A, La Spina M, Azzolini M, Parrasia S, Szabo I, Zoratti M (2019) Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds. Eur J Med Chem 181:111557
Biasutto L, Mattarei A, Azzolini M, La Spina M, Sassi N, Romio M, Paradisi C, Zoratti M (2017) Resveratrol derivatives as a pharmacological tool. Ann N Y Acad Sci 1403:27–37
Biasutto L, Mattarei A, Sassi N, Azzolini M, Romio M, Paradisi C, Zoratti M (2014) Improving the efficacy of plant polyphenols. Anti Cancer Agents Med Chem 14:1332–1342
Wallace DC (2012) Mitochondria and cancer. Nat Rev Cancer 12:685–698
Denisenko TV, Gorbunova AS, Zhivotovsky B (2019) Mitochondrial involvement in migration, invasion and metastasis. Front Cell Dev Biol 7:355
Sica V, Bravo-San Pedro JM, Stoll G, Kroemer G (2020) Oxidative phosphorylation as a potential therapeutic target for cancer therapy. Int J Cancer 146:10–17
Biasutto L, Mattarei A, Marotta E, Bradaschia A, Sassi N, Garbisa S, Zoratti M, Paradisi C (2008) Development of mitochondria-targeted derivatives of resveratrol. Bioorg Med Chem Lett 18:5594–5597
Mattarei A, Biasutto L, Marotta E, De Marchi U, Sassi N, Garbisa S, Zoratti M, Paradisi C (2008) A mitochondriotropic derivative of quercetin: a strategy to increase the effectiveness of polyphenols. Chembiochem 9:2633–2642
Mattarei A, Sassi N, Durante C, Biasutto L, Sandonà G, Marotta E, Garbisa S, Gennaro A, Paradisi C, Zoratti M (2011) Redox properties and cytotoxicity of synthetic isomeric Mitochondriotropic derivatives of the natural polyphenol quercetin. Eur J Org Chem 2011:5577–5586
Sassi N, Biasutto L, Mattarei A, Carraro M, Giorgio V, Citta A, Bernardi P, Garbisa S, Szabo I, Paradisi C et al (2012) Cytotoxicity of a mitochondriotropic quercetin derivative: mechanisms. Biochim Biophys Acta 1817:1095–1106
Sassi N, Mattarei A, Azzolini M, Bernardi P, Szabo I, Paradisi C, Zoratti M, Biasutto L (2014) Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidants. Curr Pharm Des 20:172–179
Murphy MP (2008) Targeting lipophilic cations to mitochondria. Biochim Biophys Acta 1777:1028–1031
Smith RA, Hartley RC, Cocheme HM, Murphy MP (2012) Mitochondrial pharmacology. Trends Pharmacol Sci 33:341–352
Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG et al (2009) An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta 1787:437–461
Bouktaib M, Lebrun S, Atmani A, Rolando C (2002) Hemisynthesis of all the O-monomethylated analogues of quercetin including the major metabolites, through selective protection of phenolic functions. Tetrahedron 58:10001–10009
Rao KV, Owoyale JA (1976) Partial methylation of quercetin: direct synthesis of tamarixetin, ombuin and ayanin. J Heterocyclic Chem 13:1293–1295
Slabbert NP (1977) Ionisation of some flavanols and dihydroflavonols. Tetrahedron 33:821–824
Mattarei A, Biasutto L, Rastrelli F, Garbisa S, Marotta E, Zoratti M, Paradisi C (2010) Regioselective O-derivatization of quercetin via ester intermediates. An improved synthesis of rhamnetin and development of a new mitochondriotropic derivative. Molecules (Basel, Switzerland) 15:4722–4736
Metodiewa D, Jaiswal AK, Cenas N, Dickancaite E, Segura-Aguilar J (1999) Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26:107–116
Lolli G, Cozza G, Mazzorana M, Tibaldi E, Cesaro L, Donella-Deana A, Meggio F, Venerando A, Franchin C, Sarno S et al (2012) Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight. Biochemistry 51:6097–6107
Serviddio G, Sastre J (2010) Measurement of mitochondrial membrane potential and proton leak. Methods Mol Biol 594:107–121
Burgess J (1978) Metal ions in solution. Ellis Horwood Ltd, Chichester
Gritti F, Guiochon G (2006) Influence of the degree of coverage of C18-bonded stationary phases on the mass transfer mechanism and its kinetics. J Chromatogr A 1128:45–60
McCalley DV (2010) The challenges of the analysis of basic compounds by high performance liquid chromatography: some possible approaches for improved separations. J Chromatogr A 1217:858–880
Acknowledgments
We thank Dr. M. Zoratti for support and useful discussions. This work was supported by grants from the Fondazione Cassa di Risparmio di Padova e Rovigo (CARIPARO) (“Developing a Pharmacology of Polyphenols ”), from the Italian Ministry of the University and Research (PRIN n. 20107Z8XBW_004), and by the CNR Project of Special Interest on Aging.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Biasutto, L., Mattarei, A., Paradisi, C. (2021). Synthesis and Testing of Novel Isomeric Mitochondriotropic Derivatives of Resveratrol and Quercetin . In: Weissig, V., Edeas, M. (eds) Mitochondrial Medicine . Methods in Molecular Biology, vol 2275. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1262-0_9
Download citation
DOI: https://doi.org/10.1007/978-1-0716-1262-0_9
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-1261-3
Online ISBN: 978-1-0716-1262-0
eBook Packages: Springer Protocols